ibuprofen has been researched along with Infections, Pseudomonas in 26 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibuprofen did not increase the pulmonary burden of Pseudomonas, and the ibuprofen-treated infected animals gained weight better than placebo-treated controls." | 5.28 | Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis. ( Davis, PB; Konstan, MW; Vargo, KM, 1990) |
| "Hypochlorous acid (HOCl), a neutrophil-generated oxidant, has been implicated in tissue destruction in sepsis-induced acute lung injury (ALI)." | 3.68 | Ibuprofen attenuates hypochlorous acid production from neutrophils in porcine acute lung injury. ( Byrne, K; Carey, PD; Fowler, AA; Jenkins, JK; Sielaff, TD; Sugerman, HJ; Walsh, CJ, 1990) |
| "Porcine Pseudomonas adult respiratory distress syndrome (ARDS) has been shown to respond to combination therapy of 150 mg of cimetidine, 12." | 3.67 | Successful treatment of adult respiratory distress syndrome by histamine and prostaglandin blockade in a porcine Pseudomonas model. ( Blocher, CR; Sielaff, TD; Sugerman, HJ; Tatum, JL, 1987) |
| "The effects of ibuprofen (I) and methylprednisolone (M) were studied in the Pseudomonas porcine model of adult respiratory distress syndrome (ARDS)." | 3.67 | Ibuprofen and methylprednisolone in a pig Pseudomonas ARDS model. ( Blocher, CR; Harvey, CF; Lee, EC; Sielaff, TD; Sugerman, HJ; Tatum, JL, 1987) |
| " We investigated, in an animal model, whether a non-steroidal anti-inflammatory drug, ibuprofen, reduced lung inflammation produced by P." | 3.67 | Ibuprofen modifies the inflammatory response of the murine lung to Pseudomonas aeruginosa. ( Bellanti, JA; Cerquetti, MC; el-Tawil, G; Hooke, AM; Ramwell, PW; Sordelli, DO, 1985) |
| " Non-steroid anti-inflammatory drugs have shown the antimicrobial potential to be used in combination with antibiotics against bacterial pathogens." | 1.72 | Evaluation of the effect of ibuprofen in combination with ciprofloxacin on the virulence-associated traits, and efflux pump genes of Pseudomonas aeruginosa. ( Ghanbari, F; Khodaparast, S; Zamani, H, 2022) |
| "Fournier's gangrene is a rare but life-threatening disease characterized by necrotizing fasciitis of the perineal area." | 1.36 | [An unusual presentation of Fournier's gangrene. Is there a relationship with NSAID use? Pediatric case report]. ( Florez, ID; Garcés, C; Gómez, C; Muñoz, JD, 2010) |
| "Ibuprofen pretreatment attenuates the enhanced neutrophil (PMN) respiratory burst and reduces increased plasma tumor necrosis factor (TNF) activity in porcine sepsis-induced acute lung injury (ALI)." | 1.28 | Delayed cyclo-oxygenase blockade reduces the neutrophil respiratory burst and plasma tumor necrosis factor levels in sepsis-induced acute lung injury. ( Byrne, K; Carey, PD; Fowler, AA; Leeper-Woodford, SK; Sugerman, HJ; Walsh, CJ, 1991) |
| "Ibuprofen pretreatment of septic animals completely blocked leakage of plasma proteins into the alveoli and attenuated neutrophil migration but did not prevent downregulation of AM O2-." | 1.28 | Sepsis-induced lung injury and the effects of ibuprofen pretreatment. Analysis of early alveolar events via repetitive bronchoalveolar lavage. ( Byrne, K; Carey, PD; Fowler, AA; Jenkins, JK; Sugerman, HJ, 1991) |
| "Ibuprofen did not increase the pulmonary burden of Pseudomonas, and the ibuprofen-treated infected animals gained weight better than placebo-treated controls." | 1.28 | Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis. ( Davis, PB; Konstan, MW; Vargo, KM, 1990) |
| "Ibuprofen at high doses was found to significantly diminish the hypermetabolic response to burn injury and sepsis." | 1.28 | The effect of ibuprofen on postburn metabolic and immunologic function. ( Waymack, JP, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (38.46) | 18.7374 |
| 1990's | 11 (42.31) | 18.2507 |
| 2000's | 1 (3.85) | 29.6817 |
| 2010's | 2 (7.69) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Babaei, N | 1 |
| Rasti, B | 1 |
| Zamani, H | 2 |
| Khodaparast, S | 1 |
| Ghanbari, F | 1 |
| Dai, L | 1 |
| Wu, TQ | 1 |
| Xiong, YS | 1 |
| Ni, HB | 1 |
| Ding, Y | 1 |
| Zhang, WC | 1 |
| Chu, SP | 1 |
| Ju, SQ | 1 |
| Yu, J | 1 |
| Garcés, C | 1 |
| Gómez, C | 1 |
| Florez, ID | 1 |
| Muñoz, JD | 1 |
| Saliba, AM | 1 |
| Nascimento, DO | 1 |
| Silva, MC | 1 |
| Assis, MC | 1 |
| Gayer, CR | 1 |
| Raymond, B | 1 |
| Coelho, MG | 1 |
| Marques, EA | 1 |
| Touqui, L | 1 |
| Albano, RM | 1 |
| Lopes, UG | 1 |
| Paiva, DD | 1 |
| Bozza, PT | 1 |
| Plotkowski, MC | 1 |
| Kopolovic, R | 1 |
| Thrailkill, KM | 1 |
| Martin, DT | 1 |
| Ambrose, T | 1 |
| Vento, M | 1 |
| Carey, LC | 1 |
| Cloutier, CT | 2 |
| Leeper-Woodford, SK | 3 |
| Carey, D | 1 |
| Byrne, K | 9 |
| Walsh, C | 1 |
| Fisher, B | 1 |
| Sugerman, HJ | 13 |
| Fowler, AA | 7 |
| Tamura, T | 1 |
| Carey, PD | 8 |
| Jenkins, JK | 4 |
| Walsh, CJ | 3 |
| Thompson, AB | 1 |
| Smits, WL | 1 |
| Fick, RB | 1 |
| Fisher, BJ | 1 |
| Blocher, C | 1 |
| Sielaff, TD | 7 |
| Blocher, CR | 6 |
| Cooper, KR | 1 |
| Konstan, MW | 1 |
| Vargo, KM | 1 |
| Davis, PB | 1 |
| Michna, B | 1 |
| Vasquez, A | 2 |
| Tatum, JL | 5 |
| Hirsh, JI | 1 |
| Davies, EA | 1 |
| Campbell, AJ | 1 |
| Devine, MJ | 1 |
| Steinberg, SM | 1 |
| Waymack, JP | 1 |
| van der Meer, JW | 1 |
| Lee, CC | 1 |
| Wright, TP | 1 |
| Hirsh, PD | 1 |
| Hirsch, JI | 1 |
| Harvey, CF | 1 |
| Lee, EC | 1 |
| Kellum, JM | 1 |
| Sordelli, DO | 1 |
| Cerquetti, MC | 1 |
| el-Tawil, G | 1 |
| Ramwell, PW | 1 |
| Hooke, AM | 1 |
| Bellanti, JA | 1 |
1 review available for ibuprofen and Infections, Pseudomonas
| Article | Year |
|---|---|
Immunomodulatory therapies for cystic fibrosis.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Expectorants; Humans; Ibuprofen; Immunotherapy; Interferon-g | 1992 |
25 other studies available for ibuprofen and Infections, Pseudomonas
| Article | Year |
|---|---|
Does ibuprofen affect the expression of alginate genes in pathogenic Pseudomonas aeruginosa strains?
Topics: Alginates; Anti-Bacterial Agents; Biofilms; Cystic Fibrosis; Humans; Ibuprofen; Pseudomonas aerugino | 2022 |
Evaluation of the effect of ibuprofen in combination with ciprofloxacin on the virulence-associated traits, and efflux pump genes of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Humans; Ibuprofen; Membrane | 2022 |
Ibuprofen-mediated potential inhibition of biofilm development and quorum sensing in Pseudomonas aeruginosa.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bacterial Proteins; Biofilms; Gene Expression Regulation, B | 2019 |
[An unusual presentation of Fournier's gangrene. Is there a relationship with NSAID use? Pediatric case report].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Debridement; Fatal Outcome; Fournier Gangrene; Humans; Ibup | 2010 |
Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Bacterial Pro | 2005 |
Effects of ibuprofen on a porcine model of acute respiratory failure.
Topics: Acute Disease; Animals; Disease Models, Animal; Hemodynamics; Ibuprofen; Lung; Male; Pseudomonas Inf | 1984 |
Histamine receptor antagonists, cyclooxygenase blockade, and tumor necrosis factor during acute septic insult.
Topics: Animals; Bacteremia; Blood Pressure; Cardiac Output; Cimetidine; Cyclooxygenase Inhibitors; Diphenhy | 1998 |
[Use of antibiotics and side effects of an anti-inflammatory agent, ibuprofen, in the aged].
Topics: Aged; Bacitracin; Colistin; Female; Humans; Ibuprofen; Phenylpropionates; Pregnancy; Pseudomonas Inf | 1977 |
The neutrophil respiratory burst and tissue injury in septic acute lung injury: the effect of cyclooxygenase inhibition in swine.
Topics: Acute Disease; Animals; Bronchoalveolar Lavage Fluid; Capillaries; Ibuprofen; Kinetics; Leukocyte Co | 1992 |
Delayed cyclo-oxygenase blockade reduces the neutrophil respiratory burst and plasma tumor necrosis factor levels in sepsis-induced acute lung injury.
Topics: Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cyclooxygenase Inhibitors; Extravascu | 1991 |
Ibuprofen attenuates plasma tumor necrosis factor activity during sepsis-induced acute lung injury.
Topics: Acute Disease; Animals; Blood Gas Analysis; Blood Pressure; Cardiac Output; Extravascular Lung Water | 1991 |
Sepsis-induced lung injury and the effects of ibuprofen pretreatment. Analysis of early alveolar events via repetitive bronchoalveolar lavage.
Topics: Animals; Blood Pressure; Bronchoalveolar Lavage Fluid; Extravascular Lung Water; Female; Ibuprofen; | 1991 |
Ibuprofen prevents deterioration in static transpulmonary compliance and transalveolar protein flux in septic porcine acute lung injury.
Topics: Acute Disease; Animals; Blood Pressure; Bronchoalveolar Lavage Fluid; Capillary Permeability; Extrav | 1991 |
Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis.
Topics: Animals; Body Weight; Chronic Disease; Cystic Fibrosis; Dinoprostone; Humans; Ibuprofen; Leukotriene | 1990 |
Ibuprofen attenuates hypochlorous acid production from neutrophils in porcine acute lung injury.
Topics: Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cyclooxygenase Inhibitors; Extravascu | 1990 |
Increased survival time after delayed histamine and prostaglandin blockade in a porcine model of severe sepsis-induced lung injury.
Topics: Animals; Cimetidine; Diphenhydramine; Drug Therapy, Combination; Extravascular Lung Water; Hemodynam | 1990 |
Ranitidine compared to cimetidine in multiagent pharmacological treatment of porcine Pseudomonas ARDS.
Topics: Animals; Cimetidine; Diphenhydramine; Drug Therapy, Combination; Hemodynamics; Ibuprofen; Pseudomona | 1990 |
Ibuprofen plus prostaglandin E1 in a septic porcine model of adult respiratory distress syndrome.
Topics: Alprostadil; Animals; Disease Models, Animal; Drug Therapy, Combination; Hemodynamics; Ibuprofen; Ps | 1989 |
The effect of ibuprofen on postburn metabolic and immunologic function.
Topics: Animals; Burns; Complement C3; Ibuprofen; Immunoglobulin G; Pseudomonas Infections; Rats; Rats, Inbr | 1989 |
The effects of recombinant interleukin-1 and recombinant tumor necrosis factor on non-specific resistance to infection.
Topics: Adjuvants, Immunologic; Animals; Endotoxins; Female; Ibuprofen; Immunity, Innate; Interleukin-1; Kle | 1988 |
Effects of ibuprofen on a pig Pseudomonas ARDS model.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Carbon Dioxide; Cardiac Output; Disease Model | 1986 |
Successful treatment of adult respiratory distress syndrome by histamine and prostaglandin blockade in a porcine Pseudomonas model.
Topics: Animals; Cimetidine; Diphenhydramine; Drug Therapy, Combination; Hemodynamics; Ibuprofen; Ketanserin | 1987 |
Ibuprofen and methylprednisolone in a pig Pseudomonas ARDS model.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Capillary Permeability; Disease Models, Anima | 1987 |
Treatment of porcine Pseudomonas ARDS with combination drug therapy.
Topics: Animals; Blood Pressure; Capillary Permeability; Cardiac Output; Cimetidine; Diphenhydramine; Drug C | 1987 |
Ibuprofen modifies the inflammatory response of the murine lung to Pseudomonas aeruginosa.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprostone; Disease Models, Animal; Ibuprofen; Inflammation | 1985 |